Literature DB >> 36090242

Neurogenic Bowel Dysfunction Over the Course of Multiple Sclerosis: A Review.

Elsie E Gulick1.   

Abstract

Neurogenic bowel dysfunction ranks as one of the most frequent problems experienced by people with multiple sclerosis (MS); it is one of the first symptoms to appear at disease onset and continues throughout the course of the disease. This review, based on literature searches of Medline and PubMed, examines bowel dysfunction causes and cofactors (ie, impaired mobility, fatigue, depression and anxiety, childbirth) that occur over the course of the disease. Coverage includes management of bowel dysfunction with noninvasive methods, including diet and fluid intake, together with pharmacologic treatments for constipation and fecal incontinence as well as more advanced treatments (ie, biofeedback, abdominal massage, transanal irrigation, posterior tibial nerve stimulation), caregiver-provided treatments and extended care facilities. Bowel dysfunction problems and related cofactors impact quality of life throughout the MS disease course, requiring appropriate interventions to improve and/or maintain the quality of life of the individual with MS.
© 2022 Consortium of Multiple Sclerosis Centers.

Entities:  

Keywords:  management of daily activities; multiple sclerosis; neurogenic bowel dysfunction; quality of life

Year:  2022        PMID: 36090242      PMCID: PMC9461721          DOI: 10.7224/1537-2073.2021-007

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  66 in total

Review 1.  Efficacy and safety of laxatives for chronic constipation in long-term care settings: A systematic review.

Authors:  N Alsalimy; L Madi; A Awaisu
Journal:  J Clin Pharm Ther       Date:  2018-06-09       Impact factor: 2.512

2.  Prospective comparison of faecal incontinence grading systems.

Authors:  C J Vaizey; E Carapeti; J A Cahill; M A Kamm
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

3.  Patient-reported outcomes are worse for progressive-onset multiple sclerosis than relapse-onset multiple sclerosis, particularly early in the disease process.

Authors:  Y Zhang; B V Taylor; S Simpson; L Blizzard; I van der Mei
Journal:  Eur J Neurol       Date:  2018-09-24       Impact factor: 6.089

Review 4.  Management of bowel dysfunction in people with multiple sclerosis.

Authors:  Anna Bywater; Alison While
Journal:  Br J Community Nurs       Date:  2006-08

5.  Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea.

Authors:  K R Palmer; C L Corbett; C D Holdsworth
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

Review 6.  Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies.

Authors:  Ranan DasGupta; Clare J Fowler
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Anal sphincter dysfunction in multiple sclerosis: an observation manometric study.

Authors:  Silvia Marola; Alessia Ferrarese; Enrico Gibin; Marco Capobianco; Antonio Bertolotto; Stefano Enrico; Mario Solej; Valter Martino; Ines Destefano; Mario Nano
Journal:  Open Med (Wars)       Date:  2016-11-25

8.  The frequency of bowel and bladder problems in multiple sclerosis and its relation to fatigue: A single centre experience.

Authors:  Sophia D Lin; Jane E Butler; Claire L Boswell-Ruys; Phu Hoang; Tom Jarvis; Simon C Gandevia; Euan J McCaughey
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

Review 9.  Pharmacological Management of Neurogenic Bowel Dysfunction after Spinal Cord Injury and Multiple Sclerosis: A Systematic Review and Clinical Implications.

Authors:  Jeffery S Johns; Klaus Krogh; Karen Ethans; Joanne Chi; Matthew Querée; Janice J Eng
Journal:  J Clin Med       Date:  2021-02-22       Impact factor: 4.241

10.  Relational Satisfaction of Spousal/Partner Informal Caregivers of People with Multiple Sclerosis: Relational Commitment, Caregiving Burden, and Prorelational Behavioral Tendencies.

Authors:  Moira Tzitzika; Efthymios Lampridis; Dimitris Kalamaras
Journal:  Int J MS Care       Date:  2020 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.